Treatment of ankylosing spondylitis with pamidronate: an open label study.
作者信息
Grover R, Shankar S, Aneja R, Marwaha V, Gupta R, Kumar A
出版信息
Ann Rheum Dis. 2006 May;65(5):688-9. doi: 10.1136/ard.2005.041392.
Abstract
摘要
相似文献
1
Treatment of ankylosing spondylitis with pamidronate: an open label study.帕米膦酸盐治疗强直性脊柱炎：一项开放标签研究。
Ann Rheum Dis. 2006 May;65(5):688-9. doi: 10.1136/ard.2005.041392.
2
An open study of pulse pamidronate treatment in severe ankylosing spondylitis, and its effect on biochemical markers of bone turnover.一项关于脉冲式帕米膦酸盐治疗重度强直性脊柱炎及其对骨转换生化标志物影响的开放性研究。
Ann Rheum Dis. 2005 Feb;64(2):338-9. doi: 10.1136/ard.2004.022871. Epub 2004 Apr 19.
3
Transient efficacy of pulse pamidronate treatment in active spondylarthropathies: an open study of 35 cases.脉冲帕米膦酸盐治疗活动性脊柱关节病的短期疗效：一项35例的开放性研究。
Clin Exp Rheumatol. 2006 May-Jun;24(3):348.
4
The synergistic efficacy of adalimumab and pamidronate in a patient with ankylosing spondylitis.阿达木单抗和帕米膦酸二钠联合治疗强直性脊柱炎患者的疗效。
Clin Rheumatol. 2010 Jul;29(7):793-4. doi: 10.1007/s10067-010-1378-6. Epub 2010 Jan 29.
5
New therapies for ankylosing spondylitis: etanercept, thalidomide, and pamidronate.强直性脊柱炎的新疗法：依那西普、沙利度胺和帕米膦酸盐。
Rheum Dis Clin North Am. 2003 Aug;29(3):481-94, viii. doi: 10.1016/s0889-857x(03)00028-0.
6
Treatment of active ankylosing spondylitis with pamidronate.帕米膦酸盐治疗活动性强直性脊柱炎
Rheumatology (Oxford). 2003 Aug;42(8):1018-20. doi: 10.1093/rheumatology/keg256.
7
Antiinflammatory treatment with bisphosphonates in ankylosing spondylitis.双膦酸盐在强直性脊柱炎中的抗炎治疗
Curr Opin Rheumatol. 2007 Jul;19(4):340-5. doi: 10.1097/BOR.0b013e328133f57b.
8
Assessment of the efficacy of pamidronate in ankylosing spondylitis: an open prospective trial.帕米膦酸二钠治疗强直性脊柱炎疗效评估：一项开放性前瞻性试验。
Singapore Med J. 2010 Nov;51(11):883-7.
9
An open study of pamidronate in the treatment of refractory ankylosing spondylitis.帕米膦酸治疗难治性强直性脊柱炎的开放性研究。
J Rheumatol. 1998 Apr;25(4):714-7.
10
Pamidronate--a promising new candidate for the management of spondyloarthropathy.
Indian J Med Sci. 2005 Apr;59(4):165-70.
引用本文的文献
1
How Has Molecular Biology Enhanced Our Undertaking of axSpA and Its Management.分子生物学如何增强我们对 axSpA 及其管理的认识。
Curr Rheumatol Rep. 2023 Jan;25(1):12-33. doi: 10.1007/s11926-022-01092-4. Epub 2022 Oct 29.
2
Bone mineral density improves during 2 years of treatment with bisphosphonates in patients with ankylosing spondylitis.在强直性脊柱炎患者中，使用双膦酸盐治疗2年期间骨密度得到改善。
Br J Clin Pharmacol. 2021 Feb;87(2):644-651. doi: 10.1111/bcp.14431. Epub 2020 Jul 5.
3
Rheumatology science and practice in India.印度的风湿病学科学与实践。
Rheumatol Int. 2018 Sep;38(9):1587-1600. doi: 10.1007/s00296-018-4111-4. Epub 2018 Jul 19.
4
Therapies of Early, Advanced, and Late Onset Forms of Axial Spondyloarthritis, and the Need for Treat to Target Strategies.早期、进展期和迟发型轴性脊柱关节炎的治疗方法以及靶向治疗策略的必要性。
Curr Rheumatol Rep. 2017 Feb;19(2):8. doi: 10.1007/s11926-017-0633-0.
5
Intravenous pamidronate for refractory rheumatoid arthritis.静脉注射帕米膦酸盐治疗难治性类风湿关节炎。
J Res Med Sci. 2012 May;17(5):422-7.
6
Pamidronate treatment in rheumatology practice: a comprehensive review.帕米膦酸盐在风湿病学实践中的治疗：全面综述。
Clin Rheumatol. 2009 Dec;28(12):1359-64. doi: 10.1007/s10067-009-1256-2. Epub 2009 Aug 19.
7
A systematic MEDLINE analysis of therapeutic approaches in ankylosing spondylitis.一项关于强直性脊柱炎治疗方法的MEDLINE系统分析。
Rheumatol Int. 2009 Aug;29(10):1123-35. doi: 10.1007/s00296-009-0973-9. Epub 2009 Jun 28.
本文引用的文献
1
An open study of pulse pamidronate treatment in severe ankylosing spondylitis, and its effect on biochemical markers of bone turnover.一项关于脉冲式帕米膦酸盐治疗重度强直性脊柱炎及其对骨转换生化标志物影响的开放性研究。
Ann Rheum Dis. 2005 Feb;64(2):338-9. doi: 10.1136/ard.2004.022871. Epub 2004 Apr 19.
2
Development and preselection of criteria for short term improvement after anti-TNF alpha treatment in ankylosing spondylitis.强直性脊柱炎抗TNF-α治疗后短期改善标准的制定与预选
Ann Rheum Dis. 2004 Nov;63(11):1438-44. doi: 10.1136/ard.2003.016717. Epub 2004 Mar 25.
3
Treatment of active ankylosing spondylitis with pamidronate.帕米膦酸盐治疗活动性强直性脊柱炎
Rheumatology (Oxford). 2003 Aug;42(8):1018-20. doi: 10.1093/rheumatology/keg256.
4
Bisphosphonates--targeting bone in the treatment of spondyloarthritis.双膦酸盐——用于脊柱关节炎治疗的靶向骨骼药物
Clin Exp Rheumatol. 2002 Nov-Dec;20(6 Suppl 28):S162-6.
5
A six-month randomized, controlled, double-blind, dose-response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of nonsteroidal antiinflammatory drug-refractory ankylosing spondylitis.静脉注射帕米膦酸二钠（60毫克与10毫克）治疗非甾体抗炎药难治性强直性脊柱炎的六个月随机、对照、双盲、剂量反应比较。
Arthritis Rheum. 2002 Mar;46(3):766-73. doi: 10.1002/art.10139.
6
Ankylosing spondylitis assessment group preliminary definition of short-term improvement in ankylosing spondylitis.强直性脊柱炎评估小组对强直性脊柱炎短期改善的初步定义。
Arthritis Rheum. 2001 Aug;44(8):1876-86. doi: 10.1002/1529-0131(200108)44:8<1876::AID-ART326>3.0.CO;2-F.
7
Collapsing focal segmental glomerulosclerosis following treatment with high-dose pamidronate.大剂量帕米膦酸治疗后出现的塌陷型局灶节段性肾小球硬化
J Am Soc Nephrol. 2001 Jun;12(6):1164-1172. doi: 10.1681/ASN.V1261164.
8
9
An open study of pamidronate in the treatment of refractory ankylosing spondylitis.帕米膦酸治疗难治性强直性脊柱炎的开放性研究。
J Rheumatol. 1998 Apr;25(4):714-7.
10
Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria.强直性脊柱炎诊断标准的评估。对纽约标准进行修订的提议。
Arthritis Rheum. 1984 Apr;27(4):361-8. doi: 10.1002/art.1780270401.
Zotero 插件